Use of oral antidiabetic drugs in the treatment of maturity-onset diabetes of the young: A mini review.

about

Hidden MODY-Looking for a Needle in a Haystack.

P2860

Q55715140-D97FDAEC-5834-403D-911A-5E175A559D88

P2860

Use of oral antidiabetic drugs in the treatment of maturity-onset diabetes of the young: A mini review.

Item

http://www.wikidata.org/entity/Q48176468

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Use of oral antidiabetic drugs ...... s of the young: A mini review.

@en

Use of oral antidiabetic drugs ...... s of the young: A mini review.

@nl

type

Item

label

Use of oral antidiabetic drugs ...... s of the young: A mini review.

@en

Use of oral antidiabetic drugs ...... s of the young: A mini review.

@nl

prefLabel

Use of oral antidiabetic drugs ...... s of the young: A mini review.

@en

Use of oral antidiabetic drugs ...... s of the young: A mini review.

@nl

P1476

Use of oral antidiabetic drugs ...... es of the young: A mini review

@en

P2093

Dario Rahelić

http://www.w3.org/2001/XMLSchema#string

Jan Broz

http://www.w3.org/2001/XMLSchema#string

Ludmila Brunerova

http://www.w3.org/2001/XMLSchema#string

P2860

Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a-/- Model

Three new mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with diabetes mellitus: clinical features and functional characterization

Monogenic diabetes and pregnancy

Genetic cause of hyperglycaemia and response to treatment in diabetes

Precision diabetes: learning from monogenic diabetes.

Pharmacological stimulation and inhibition of insulin secretion in mouse islets lacking ATP-sensitive K+ channels

Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.

The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes.

Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.

Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes.

P31

scholarly article

P356

10.1002/DMRR.2940

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28840639

http://www.w3.org/2001/XMLSchema#string

Use of oral antidiabetic drugs in the treatment of maturity-onset diabetes of the young: A mini review.

about

P2860

P2860

Use of oral antidiabetic drugs in the treatment of maturity-onset diabetes of the young: A mini review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698